Cholangitis is an infection and inflammation of the bile ducts, the tubes that carry bile from your liver to your small intestine. It most often happens when something blocks the flow of bile, allowing bacteria to build up and spread through the biliary system. Without treatment, cholangitis can progress rapidly from a manageable infection to life-threatening sepsis, making it a medical emergency in its more severe forms.
How Bile Duct Infection Develops
Your bile ducts have a built-in defense system. The duct lining produces antibodies that prevent bacteria from sticking to the walls, and the steady flow of bile flushes microbes out before they can multiply. When something blocks that flow, pressure builds inside the ducts. Once the pressure overwhelms the duct lining’s natural defenses, bacteria multiply rapidly and can spill into the bloodstream and lymphatic system.
The most common culprits found in infected bile are gut bacteria that travel backward up the duct system. E. coli accounts for 25 to 50% of cases, followed by Klebsiella (15 to 20%) and Enterococcus species (10 to 20%). In severe or prolonged infections, multiple bacterial species are often present simultaneously.
What Causes the Blockage
Gallstones lodged in the common bile duct are by far the most frequent trigger. About 10 to 15% of the adult U.S. population develops gallstones, and among those people, 10 to 15% also have stones in the common bile duct at the time of diagnosis. These stones can physically block bile flow, and bacteria colonize the stone surface in a sticky biofilm, worsening the infection.
Beyond gallstones, several other conditions can obstruct bile flow:
- Bile duct tumors (cholangiocarcinoma), pancreatic head cancer, or tumors at the junction where the bile duct meets the intestine
- Strictures from scarring after surgery, prior stone passage, or chronic inflammatory conditions
- Cysts in the bile duct system
- Parasitic infections, particularly liver flukes and roundworms, which are more common in parts of Asia
- Autoimmune conditions that cause chronic inflammation and narrowing of the ducts
Types of Cholangitis
The term “cholangitis” covers several distinct conditions, and the differences between them matter because the causes, who they affect, and how they’re treated vary significantly.
Acute Cholangitis
This is the most urgent form. It develops over hours to days when a sudden blockage traps bacteria in the bile ducts. It requires prompt treatment with antibiotics and, in most cases, a procedure to relieve the obstruction. Before surgical drainage techniques were developed in the early 1900s, mortality from acute cholangitis approached 100%. Even today, current mortality rates range from about 10% to 37% depending on severity.
Primary Sclerosing Cholangitis (PSC)
PSC is a chronic condition in which ongoing inflammation causes scarring and narrowing of the medium and large bile ducts, both inside and outside the liver. Over time, the scarring creates a distinctive “beading” pattern visible on imaging, where narrowed segments alternate with dilated ones. PSC is twice as common in men and typically diagnosed between ages 30 and 40. Its cause remains unknown, though it’s strongly linked to inflammatory bowel disease.
Primary Biliary Cholangitis (PBC)
PBC is an autoimmune disease that attacks the small bile ducts inside the liver. The immune system slowly destroys these tiny ducts, eventually leading to bile buildup and liver damage. PBC overwhelmingly affects women, with a female-to-male ratio of 10 to 1, and is most often diagnosed in middle-aged to older women. A specific blood marker called antimitochondrial antibodies is present in nearly all cases and helps confirm the diagnosis.
Symptoms and Warning Signs
The classic combination of symptoms in acute cholangitis is known as Charcot’s triad: fever with chills, pain in the upper right abdomen, and jaundice (yellowing of the skin and eyes). In practice, though, this full set of three symptoms appears in only about 15 to 30% of patients. Older adults are even less likely to present with the complete triad, with one study finding it in just 9% of patients aged 80 and older.
When the infection becomes severe, two additional signs can emerge: low blood pressure and confusion or altered consciousness. Together with the original three symptoms, these five findings are called Reynolds’ pentad. The complete pentad appears in fewer than 5% of patients, but when it does, it signals a dangerous progression toward septic shock and organ failure.
Many people with cholangitis present with only one or two of these symptoms. Fever is often the earliest and most reliable sign. Jaundice may take longer to develop, and some patients, particularly older adults, may show confusion as a primary symptom without obvious abdominal pain.
How Cholangitis Is Diagnosed
Diagnosis relies on a combination of clinical signs, blood work, and imaging. Blood tests typically reveal elevated markers of infection and inflammation, along with high levels of bilirubin and liver enzymes that indicate bile isn’t flowing properly.
Imaging plays a key role in identifying what’s causing the blockage. Ultrasound is usually the first test performed because it’s fast, widely available, and good at detecting dilated bile ducts. Its sensitivity for finding the underlying cause of obstruction sits around 75% for benign causes like gallstones. CT scans improve on that, with sensitivity around 87 to 88%. The most accurate imaging tool is MRCP (magnetic resonance cholangiopancreatography), a specialized MRI that maps the bile ducts in detail. MRCP reaches nearly 98% sensitivity and accuracy for benign causes of obstruction, making it the go-to test when ultrasound results are unclear.
Severity Levels
Acute cholangitis is graded into three severity levels based on how the body responds to initial treatment and whether organs begin to fail.
Mild (Grade I) cholangitis responds to initial treatment with antibiotics and supportive care. The infection is typically caused by a single type of gut bacteria, and a short course of antibiotics lasting two to three days is often sufficient. Most patients with mild cholangitis recover without needing an urgent procedure.
Moderate (Grade II) cholangitis does not improve with initial medical treatment but hasn’t yet caused organ damage. These patients need a drainage procedure to relieve the blockage, as antibiotics alone won’t resolve the infection while bile remains trapped.
Severe (Grade III) cholangitis involves at least one failing organ system. This can mean dangerously low blood pressure requiring medication to maintain circulation, kidney failure, confusion or loss of consciousness, breathing difficulties, abnormal blood clotting, or a sharp drop in platelet count. Death in severe cholangitis is most often caused by multiple organ failure from overwhelming sepsis. ICU mortality rates for severe cases run around 28%.
Treatment and Drainage
Treatment has two goals: fight the infection with antibiotics and restore bile flow by removing or bypassing the obstruction.
Antibiotics are started immediately, even before the exact bacteria are identified. The initial choice targets the gut bacteria most likely responsible. For mild cases, a single antibiotic that covers common intestinal bacteria is typically enough. More severe cases require broader coverage and intravenous delivery.
Restoring bile flow is the critical step. The two main approaches are endoscopic drainage and percutaneous drainage. In endoscopic drainage, a flexible scope is passed through the mouth, down through the stomach, and into the small intestine where it reaches the bile duct opening. From there, stones can be removed, narrowed areas can be widened, or a small tube called a stent can be placed to keep the duct open. This approach succeeds in roughly 86% of cases.
Percutaneous drainage takes a different route: a needle is inserted through the skin and liver, guided by imaging, directly into the bile duct. A drain is then left in place to allow bile to flow out. This method has a higher technical success rate of about 97% and tends to reduce bilirubin levels faster. In one study, percutaneous drainage achieved a 50% reduction in bilirubin in about 7 days compared to 10.5 days with the endoscopic approach. However, it requires more careful management afterward because of the external drain.
The choice between methods depends on the location and nature of the blockage, the patient’s anatomy, available expertise, and whether surgery is planned later. For patients with cancer-related obstruction who will undergo surgery, percutaneous drainage may serve as a better bridge because it can improve liver function and control infection more quickly, shortening the wait time before the operation.
Outlook and Complications
The prognosis for cholangitis depends almost entirely on how quickly it’s recognized and treated. Mild cases that respond promptly to antibiotics carry a good prognosis, and many patients recover fully within days. The key risk is progression: if the infection isn’t controlled and bile flow isn’t restored, bacteria flood the bloodstream. This triggers a cascade of inflammation that can damage the kidneys, lungs, liver, brain, and cardiovascular system in rapid succession.
Over the past several decades, mortality from acute cholangitis has dropped from around 50% to the 10 to 30% range, largely because of improvements in endoscopic and percutaneous drainage techniques. Still, for patients who develop severe cholangitis with organ failure, the condition remains life-threatening. Liver abscesses are another potential complication, occurring when pockets of infection form within the liver tissue itself. Recurrent cholangitis can also develop in people with ongoing risk factors like chronic bile duct strictures or stones that re-form after treatment.